BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2823151)

  • 21. c-myc protein can be substituted for SV40 T antigen in SV40 DNA replication.
    Iguchi-Ariga SM; Itani T; Yamaguchi M; Ariga H
    Nucleic Acids Res; 1987 Jun; 15(12):4889-99. PubMed ID: 3037484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [DNA replication and RNA transcription regulated by c-myc protein].
    Sanae M; Iguchi-Ariga M; Ariga H
    Tanpakushitsu Kakusan Koso; 1988 Sep; 33(11):1758-65. PubMed ID: 2468174
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of c-Myc domains involved in stimulating SV40 replication.
    Classon M; Wennborg A; Henriksson M; Klein G
    Gene; 1993 Nov; 133(2):153-61. PubMed ID: 8224903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of SV40 DNA replication by the human c-myc enhancer.
    Kumano M; Nakagawa T; Imamura Y; Galli I; Ariga H; Iguchi-Ariga SM
    FEBS Lett; 1992 Sep; 309(2):146-52. PubMed ID: 1324192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The replication activity of SV40 DNA correlates with the level of c-myc expression in human tumor cell lines.
    Henriksson M; Classon M; Hammarskjöld ML; Klein G; Sumegi J
    Curr Top Microbiol Immunol; 1988; 141():202-7. PubMed ID: 2850893
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of c-myc protein with enzymes of DNA replication in high molecular weight fractions from mammalian cells.
    Studzinski GP; Shankavaram UT; Moore DC; Reddy PV
    J Cell Physiol; 1991 Jun; 147(3):412-9. PubMed ID: 1648564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active ras and myc oncogenes can be compatible, but Sv40 large T antigen is specifically suppressed with normal differentiation of mouse embryonic stem cells.
    Suda Y; Hirai S; Suzuki M; Ikawa Y; Aizawa S
    Exp Cell Res; 1988 Sep; 178(1):98-113. PubMed ID: 2457506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mutagenic effect of the SV40 oncogene: induction of resistance to 6-mercaptopurine and serum independence].
    Marshak MI; Varshaver NB; Surkov VV; Raevskaia GB; Shapiro NI
    Genetika; 1986 Jun; 22(6):957-65. PubMed ID: 3015726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells.
    Piechaczek C; Fetzer C; Baiker A; Bode J; Lipps HJ
    Nucleic Acids Res; 1999 Jan; 27(2):426-8. PubMed ID: 9862961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposite replication polarity of the germ line c-myc gene in HeLa cells compared with that of two Burkitt lymphoma cell lines.
    Leffak M; James CD
    Mol Cell Biol; 1989 Feb; 9(2):586-93. PubMed ID: 2710118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porcine vascular smooth muscle cells immortalized with SV40 ori-defective DNA: characteristics of cell growth and collagen synthesis.
    Fujimitsu K; Sakata N; Jimi S; Takebayashi S; Sasaguri Y; Morimatsu M
    Acta Pathol Jpn; 1993 Sep; 43(9):481-9. PubMed ID: 8237368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase.
    D'Urso G; Marraccino RL; Marshak DR; Roberts JM
    Science; 1990 Nov; 250(4982):786-91. PubMed ID: 2173140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cis-acting negative control of DNA replication in eukaryotic cells.
    Roberts JM; Weintraub H
    Cell; 1988 Feb; 52(3):397-404. PubMed ID: 2830984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Eukaryotic DNA replication: analysis of reconstitution of SV40 DNA replication].
    Waga S
    Seikagaku; 1995 Sep; 67(9):1142-8. PubMed ID: 8530873
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppression of tumorigenicity in T-cell lymphoma hybrids is correlated with changes in myc expression and DNA replication of the myc chromosomal domain.
    Eul J; Gronemeyer H; Adolph S; Hameister H
    Chromosoma; 1988; 96(3):248-54. PubMed ID: 3258808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-myc protein and DNA replication: separation of c-myc antibodies from an inhibitor of DNA synthesis.
    Gutierrez C; Guo ZS; Farrell-Towt J; Ju G; DePamphilis ML
    Mol Cell Biol; 1987 Dec; 7(12):4594-8. PubMed ID: 2830501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in oncogene expression and radiosensitivity in the most frequently used SV40-transformed human skin fibroblasts.
    Lücke-Huhle C
    Int J Radiat Biol; 1994 Jun; 65(6):665-73. PubMed ID: 7912716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined bidimensional electrophoresis and electron microscopy to study specific plasmid DNA replication intermediates in human cells.
    Follonier C; Lopes M
    Methods Mol Biol; 2014; 1094():209-19. PubMed ID: 24162990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The first exon of the c-myc proto-oncogene contains a novel positive control element.
    Yang JQ; Remmers EF; Marcu KB
    EMBO J; 1986 Dec; 5(13):3553-62. PubMed ID: 3030732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autonomous replication of a DNA fragment containing the chromosomal replication origin of the human c-myc gene.
    McWhinney C; Leffak M
    Nucleic Acids Res; 1990 Mar; 18(5):1233-42. PubMed ID: 2157194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.